+7 (499) 340 10 14

Payment upon Recovery

Treatment of one hepatitis C patient costs up to 840 thousand rubles of budget funds. However, the amount may be reduced, if payments are made upon recovery, not in advance.

For that purpose for purchase of drugs for treatment of hepatitis C the Moscow region will introduce a target reimbursement risk-sharing program, where the pharmaceutical company will only receive payment on condition of successful treatment.

According to Chief Regional Hepatologist of the Ministry of Health the risk sharing program will ensure effective and affordable therapy.

The assessment of treatment success for each patient will be performed by specialists from the M.Vladimirsky Moscow Regional Clinical Institute.

LABMGMU LABMGMU +7 (499) 340 10 14 info@labmgmu.ru 119435, Moscow, Malaya Pirogovskay str. 13-1, floor 4